362 related articles for article (PubMed ID: 23937612)
1. Viewing serine/threonine protein phosphatases through the eyes of drug designers.
Zhang M; Yogesha SD; Mayfield JE; Gill GN; Zhang Y
FEBS J; 2013 Oct; 280(19):4739-60. PubMed ID: 23937612
[TBL] [Abstract][Full Text] [Related]
2. Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer.
Zhang Q; Fan Z; Zhang L; You Q; Wang L
J Med Chem; 2021 Jul; 64(13):8916-8938. PubMed ID: 34156850
[TBL] [Abstract][Full Text] [Related]
3. Small molecule inhibitors of serine/threonine protein phosphatases.
McCluskey A; Sakoff JA
Mini Rev Med Chem; 2001 May; 1(1):43-55. PubMed ID: 12369990
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development.
Swingle MR; Honkanen RE
Curr Med Chem; 2019; 26(15):2634-2660. PubMed ID: 29737249
[TBL] [Abstract][Full Text] [Related]
5. Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discovery.
Sawyer TK; Shakespeare WC; Wang Y; Sundaramoorthi R; Huang WS; Metcalf CA; Thomas M; Lawrence BM; Rozamus L; Noehre J; Zhu X; Narula S; Bohacek RS; Weigele M; Dalgarno DC
Med Chem; 2005 May; 1(3):293-319. PubMed ID: 16787325
[TBL] [Abstract][Full Text] [Related]
6. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.
Hirai G; Sodeoka M
Acc Chem Res; 2015 May; 48(5):1464-73. PubMed ID: 25894598
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms underlying inhibition of protein phosphatases by marine toxins.
Dawson JF; Holmes CF
Front Biosci; 1999 Oct; 4():D646-58. PubMed ID: 10502549
[TBL] [Abstract][Full Text] [Related]
8. Studies of small molecule interactions with protein phosphatases using biosensor technology.
Stenlund P; Frostell-Karlsson A; Karlsson OP
Anal Biochem; 2006 Jun; 353(2):217-25. PubMed ID: 16597430
[TBL] [Abstract][Full Text] [Related]
9. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
[TBL] [Abstract][Full Text] [Related]
10. Regulators of serine/threonine protein phosphatases at the dawn of a clinical era?
Honkanen RE; Golden T
Curr Med Chem; 2002 Nov; 9(22):2055-75. PubMed ID: 12369870
[TBL] [Abstract][Full Text] [Related]
11. Challenges and opportunities in the development of protein phosphatase-directed therapeutics.
De Munter S; Köhn M; Bollen M
ACS Chem Biol; 2013 Jan; 8(1):36-45. PubMed ID: 23214403
[TBL] [Abstract][Full Text] [Related]
12. A molecular modeling analysis of the binding interactions between the okadaic acid class of natural product inhibitors and the Ser-Thr phosphatases, PP1 and PP2A.
Gauss CM; Sheppeck JE; Nairn AC; Chamberlin R
Bioorg Med Chem; 1997 Sep; 5(9):1751-73. PubMed ID: 9354231
[TBL] [Abstract][Full Text] [Related]
13. A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases.
Rodems SM; Hamman BD; Lin C; Zhao J; Shah S; Heidary D; Makings L; Stack JH; Pollok BA
Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):9-19. PubMed ID: 15090152
[TBL] [Abstract][Full Text] [Related]
14. [Development of novel types of biologically active compounds based on natural products and biomolecules].
Hirai G
Yakugaku Zasshi; 2012; 132(1):117-24. PubMed ID: 22214586
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of cytostatin analogues.
Bialy L; Waldmann H
Chem Commun (Camb); 2003 Aug; (15):1872-3. PubMed ID: 12932009
[TBL] [Abstract][Full Text] [Related]
17. Protein phosphatases: structures and implications.
Jia Z
Biochem Cell Biol; 1997; 75(1):17-26. PubMed ID: 9192069
[TBL] [Abstract][Full Text] [Related]
18. Regulatory cascades of protein phosphatases: implications for cancer treatment.
Jailkhani N; Chaudhri VK; Rao KV
Anticancer Agents Med Chem; 2011 Jan; 11(1):64-77. PubMed ID: 21214508
[TBL] [Abstract][Full Text] [Related]
19. Targeting phosphatases: From molecule design to clinical trials.
Guo M; Li Z; Gu M; Gu J; You Q; Wang L
Eur J Med Chem; 2024 Jan; 264():116031. PubMed ID: 38101039
[TBL] [Abstract][Full Text] [Related]
20. Development of fluorescence-based selective assays for serine/threonine and tyrosine phosphatases.
Pastula C; Johnson I; Beechem JM; Patton WF
Comb Chem High Throughput Screen; 2003 Jun; 6(4):341-6. PubMed ID: 12769677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
